PTC THERAPEUTICS, INC. 8-K

What Happened
PTC Therapeutics, Inc. (PTCT) filed a Form 8-K on June 9, 2026 reporting that board member Alethia Young resigned from the company's Board effective June 8, 2026. The company and Ms. Young entered a Consulting Agreement effective June 8, 2026 under which she will remain as an advisor through June 8, 2027 and receive a monthly consulting fee.

Key Details

• Resignation: Alethia Young resigned from the Board effective June 8, 2026.
• Consulting term: Consulting Agreement runs from June 8, 2026 through June 8, 2027.
• Compensation: Ms. Young will be paid $4,166.67 per month under the Consulting Agreement.
• Reason: Ms. Young stated the resignation is to focus on other work commitments and not due to any disagreement with the company.

Why It Matters
This is a governance change: an experienced director is leaving the Board but remains engaged with the company in an advisory role. The consulting arrangement is modest in cost and temporary (one year), so direct financial impact is limited. Investors should note the change in Board composition and that the company disclosed the arrangement promptly in its 8-K; any further material governance changes or director replacements would be announced separately.